Maso Capital Partners’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-87,352
Closed -$4.99M 55
2021
Q1
$4.99M Sell
87,352
-36,005
-29% -$1.95M 1.92% 7
2020
Q4
$6.2M Sell
123,357
-46,971
-28% -$1.87M 1.69% 5
2020
Q3
$5.02M Hold
170,328
2.81% 7
2020
Q2
$4.28M Hold
170,328
1.73% 8
2020
Q1
$3.13M Sell
170,328
-110,772
-39% -$3.17M 0.81% 13
2019
Q4
$9.34M Buy
281,100
+38,900
+16% +$1.22M 3% 9
2019
Q3
$7.53M Buy
242,200
+104,800
+76% +$3.19M 2.7% 10
2019
Q2
$4.8M Buy
137,400
+29,200
+27% +$944K 2.52% 10
2019
Q1
$3.17M Buy
108,200
+5,900
+6% +$167K 2.18% 11
2018
Q4
$2.63M Buy
+102,300
New +$3.54M 3.3% 9

Other funds holding ACHC

Maso Capital Partners's ACHC Position: Q2 2021 in Review

Maso Capital Partners sold out of Acadia Healthcare (ACHC) in Q2 2021, closing a stake of 87,352 shares — an estimated $4.99M sold.

Maso Capital Partners first reported a position in ACHC in Q4 2018 and held it in 10 quarters. The position peaked at $9.34M in Q4 2019. 285 funds tracked by Wall St. Rank hold ACHC as of Q2 2021.

  • Maso Capital Partners reported no remaining Acadia Healthcare position as of Q2 2021 after selling out during the quarter.
  • Maso Capital Partners sold 87,352 Acadia Healthcare shares in Q2 2021, an estimated $4.99M.
  • Maso Capital Partners first reported a position in Acadia Healthcare in Q4 2018 and held it in 10 quarters.
  • Maso Capital Partners's Acadia Healthcare position peaked at $9.34M in Q4 2019.
  • 285 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2021.

Based on Maso Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.